Literature DB >> 15955223

Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients.

Ramazan Yildiz1, Bulent Yildirim, Melih Karincaoglu, Murat Harputluoglu, Fatih Hilmioglu.   

Abstract

BACKGROUND: Cirrhotic patients have a hyperdynamic systemic circulation. They have insidious cardiac problems besides well-known complications. Brain natriuretic peptide (BNP) relaxes vascular smooth muscle and has a portal hypotensive action. The relations between BNP levels and severity of disease, cardiac dysfunction and esophageal varices were studied in non-alcoholic cirrhotic patients.
METHODS: Fifty-two non-alcoholic cirrhotic patients were evaluated for decompensation component of cirrhosis. The BNP concentration of echocardiographically examined patients was determined.
RESULTS: The BNP levels were significantly higher in ascites, spontaneous bacterial peritonitis and hepatic encephalopathy history group (P = 0.033, P < 0.001, P = 0.014, respectively), but no significant difference were observed for presence of esophageal varices and bleeding history (P = 0.267, P = 0.429). A significant correlation was observed between BNP concentration and Child score (r = 0.427, P = 0.012), interventricular septal thickness (r = 0.497, P < 0.001) and left ventricular posterior wall thickness (r = 0.526, P < 0.001). According to Child-Pugh classification there were no significant difference between groups for echocardiographic measurements and blood pressure (P > 0.05), but plasma BNP levels were significantly higher in Child class B and C patients compared with class A patients (P < 0.05).
CONCLUSION: Increased levels of BNP are more likely related to the severity of disease in non-alcoholic cirrhotic patients. The advanced cirrhosis is associated with more advanced cardiac dysfunction and BNP has prognostic value in progression of cirrhosis. (c) 2005 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15955223     DOI: 10.1111/j.1440-1746.2005.03906.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  22 in total

1.  Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease.

Authors:  J G Berry; B Askovich; R E Shaddy; J A Hawkins; C G Cowley
Journal:  Pediatr Cardiol       Date:  2007-08-04       Impact factor: 1.655

Review 2.  The multifaceted role of natriuretic peptides in metabolic syndrome.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Mulugeta Seneshaw; Faridoddin Mirshahi; Arun J Sanyal
Journal:  Biomed Pharmacother       Date:  2017-06-07       Impact factor: 6.529

3.  Cirrhotic cardiomyopathy.

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2008-11-11       Impact factor: 6.047

4.  NT-proBNP and Echocardiographic Parameters in Liver Cirrhosis - Correlations with Disease Severity.

Authors:  Alexandru Radu Mihailovici; Ionuț Donoiu; Dan Ionuț Gheonea; Oana Mirea; Georgică Costinel Târtea; Maria Buşe; Veronica Calborean; Cosmin Obleagă; Vlad Pădureanu; Octavian Istrătoaie
Journal:  Med Princ Pract       Date:  2019-04-16       Impact factor: 1.927

Review 5.  Interpretation and use of natriuretic peptides in non-congestive heart failure settings.

Authors:  Shih-Hung Tsai; Yen-Yue Lin; Shi-Jye Chu; Ching-Wang Hsu; Shu-Meng Cheng
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

6.  Serum levels of N-terminal pro-B-type natriuretic peptide are associated with allograft function in recipients of renal transplants.

Authors:  Gerd Bodlaj; Rainer Hubmann; Karim Saleh; Georg Biesenbach; Erich Pohanka; Tatjana Stojakovic; Jörg Berg
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

7.  Systemic immunoglobulin light-chain amyloidosis presenting hematochezia as the initial symptom.

Authors:  Tetsuo Kon; Naoki Nakagawa; Fumitsugu Yoshikawa; Kazunao Haba; Nagako Kitagawa; Michihiro Izumi; Setsuo Kumazaki; Satoshi Ishida; Ryuichi Aikawa
Journal:  Clin J Gastroenterol       Date:  2016-06-18

8.  Heart rhythm turbulence and NT-proBNP in decompensated liver cirrhosis--a pilot study.

Authors:  Adam Rafał Poliwczak; Jolanta Białkowska; Marlena Broncel; Marzena Koziróg; Katarzyna Dworniak; Kornelia Kotecka; Maciej Jabłkowski
Journal:  Med Sci Monit       Date:  2011-06

9.  Hazardous alcohol consumption is associated with increased levels of B-type natriuretic peptide: evidence from two population-based studies.

Authors:  David A Leon; Vladimir M Shkolnikov; Svetlana Borinskaya; Juan-Pablo Casas; Alun Evans; Artyom Gil; Frank Kee; Nikolay Kiryanov; Martin McKee; Mark G O'Doherty; George B Ploubidis; Olga Polikina; Maxim Vassiliev; Stefan Blankenberg; Hugh Watkins
Journal:  Eur J Epidemiol       Date:  2013-05-05       Impact factor: 8.082

10.  New insight into the role of NT-proBNP in alcoholic liver cirrhosis as a noninvasive marker of esophageal varices.

Authors:  Neven Ljubicić; Marija Gomercić; Drazen Zekanović; Tomislava Bodrozić-Dzakić; Ana Duzel
Journal:  Croat Med J       Date:  2012-08       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.